Search

Tejal C Parekh

from Union City, NJ
Age ~34
Get Report
Also known as:
Pejal Parekh, Tejal Tarekh
Phone and address:
411 15Th St APT C4, Union City, NJ 07087
(551) 221-5870
Related to:
John Marc Amato Micele, 61Beth L Varano, 55Gloria C Hillman, 93Chandrakant C Parekh, 73Roxanne C Parekh, 69Roxanne Parekh, 34Anil Parekh, 37
Connected to:
Abhay Parekh, 82Akhil M Parekh, 40Amisha B Parekh, 49Anuj P Parekh, 30Arati J Parekh, 64Axay J Parekh, 56Bimal Parekh, 53Bina H Parekh, 55Bindi H Parekh, 45Chandresh J Parekh, 62

Tejal Parekh Phones & Addresses

  • 411 15Th St APT C4, Union City, NJ 07087 (551) 221-5870
  • Jersey City, NJ
  • Astoria, NY

Work

Company: Hudson county community college Feb 2011 Position: Staff/customer service assistant

Education

School / High School: New Jersey City University- Jersey City, NJ Sep 2011 Specialities: Psychology

Industries

Computer Software

Resumes

Resumes

Tejal Parekh Photo 1

Business Professional

View page
Location:
Jersey City, NJ
Industry:
Computer Software
Work:
Softpath System, Llc
Business Professional
Tejal Parekh Photo 2

Tejal Parekh Jersey City, NJ

View page
Work:
Hudson County Community College

Feb 2011 to Present
Staff/Customer Service Assistant
Aeropostale INC
Jersey City, NJ
May 2008 to Sep 2011
Sales Associate
Education:
New Jersey City University
Jersey City, NJ
Sep 2011
Psychology
Hudson County Community College
Jersey City, NJ
May 2011
Associate's in Arts

Business Records

Name / Title
Company / Classification
Phones & Addresses
Tejal Parekh
Secretary
Kaleidoscope USA Inc
Mfg & Whol Jewelry
1212 Ave Of The Americ, New York, NY 10036
(212) 575-1670

Publications

Us Patents

Macrocyclic Ns3-Serine Protease Inhibitors Of Hepatitis C Virus Comprising N-Cyclic P2 Moieties

View page
US Patent:
6846802, Jan 25, 2005
Filed:
Apr 3, 2001
Appl. No.:
09/825399
Inventors:
Kevin X. Chen - Piscataway NJ, US
Ashok Arasappan - Bridgewater NJ, US
Srikanth Venkatraman - Fords NJ, US
Tejal Parekh - Woodbridge NJ, US
Haining Gu - Minhang, CN
George F. Njoroge - Union NJ, US
Viyyoor Moopil Girijavallabhan - Parsippany NJ, US
Ashit Ganguly - Upper Montclair NJ, US
Anil Saksena - Upper Montclair NJ, US
Edwin Jao - Warren NJ, US
Nanhua Hugh Yao - Edison NJ, US
Andrew Joseph Prongay - Stewartsville NJ, US
Vincent Stewart Madison - Mountain Lakes NJ, US
Bancha Vibulbhan - Kenilworth NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A16K 3812
US Classification:
514 9, 514411, 540469, 530317
Abstract:
The present invention discloses novel macrocyclic compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such macrocycles as well as methods of using them to treat disorders associated with the HCV protease.

Peptides As Ns3-Serine Protease Inhibitors Of Hepatitis C Virus

View page
US Patent:
7012066, Mar 14, 2006
Filed:
Jul 19, 2001
Appl. No.:
09/908955
Inventors:
Anil K. Saksena - Upper Montclair NJ, US
Viyyoor Moopil Girijavallabhan - Parsippany NJ, US
Raymond G. Lovey - West Caldwell NJ, US
Edwin Jao - Warren NJ, US
Frank Bennett - Piscataway NJ, US
Jinping L. Mc Cormick - Edison NJ, US
Haiyan Wang - Cranbury NJ, US
Russell E. Pike - Stanhope NJ, US
Stephane L. Bogen - Somerset NJ, US
Tin-Yau Chan - Edison NJ, US
Yi-Tsung Liu - Morris Township NJ, US
Zhaoning Zhu - East Windsor NJ, US
F. George Njoroge - Warren NJ, US
Ashok Arasappan - Bridgewater NJ, US
Tejal Parekh - Mountain View CA, US
Ashit K. Ganguly - Upper Montclair NJ, US
Kevin X. Chen - Iselin NJ, US
Srikanth Venkatraman - Fords NJ, US
Henry A. Vaccaro - South Plainfield NJ, US
Patrick A. Pinto - Morris Plains NJ, US
Bama Santhanam - Bridgewater NJ, US
Scott Jeffrey Kemp - San Diego CA, US
Odile Esther Levy - San Diego CA, US
Marguerita Lim-Wilby - La Jolla CA, US
Susan Y. Tamura - Santa Fe NM, US
Wanli Wu - Edison NJ, US
Siska Hendrata - Edison NJ, US
Yuhua Huang - Scotch Plains NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
Dendreon Corporation - Seattle WA
International Classification:
A61K 38/07
A61K 38/06
C07K 5/08
C07K 5/10
US Classification:
514 18, 530330, 530331
Abstract:
The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.

Peptides As Ns3-Serine Protease Inhibitors Of Hepatitis C Virus

View page
US Patent:
7169760, Jan 30, 2007
Filed:
Jul 19, 2001
Appl. No.:
09/909012
Inventors:
Anil K. Saksena - Upper Montclair NJ, US
Viyyoor Moopil Girijavallabhan - Parsippany NJ, US
Stephane L. Bogen - Somerset NJ, US
Raymond G. Lovey - West Caldwell NJ, US
Edwin Jao - Warren NJ, US
Frank Bennett - Piscataway NJ, US
Jinping L. Mc Cormick - Edison NJ, US
Haiyan Wang - Cranbury NJ, US
Russell E. Pike - Stanhope NJ, US
Yi-Tsung Liu - Morris Township NJ, US
Tin-Yau Chan - Edison NJ, US
Zhaoning Zhu - East Windsor NJ, US
Ashok Arasappan - Bridgewater NJ, US
Kevin X. Chen - Iselin NJ, US
Srinkanth Venkatraman - Fords NJ, US
Tejal Parekh - Mountain View CA, US
Patrick A. Pinto - Morris Plains NJ, US
Bama Santhanam - Bridgewater NJ, US
F. George Njoroge - Warren NJ, US
Ashit K. Ganguly - Upper Montclair NJ, US
Henry A. Vaccaro - South Plainfield NJ, US
Scott Jeffrey Kemp - San Diego CA, US
Odile Esther Levy - San Diego CA, US
Marguerita Lim-Wilby - La Jolla CA, US
Susan Y. Tamura - Santa Fe NM, US
Assignee:
Schering Corporation - Kenilworth NJ
Dendreon Corporation - Seattle WA
International Classification:
A61K 38/05
A61K 31/44
A61K 31/16
A61K 31/227
US Classification:
514 19, 514616, 564154, 564152, 564155
Abstract:
The present invention discloses novel peptide compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.

Peptides As Ns3-Serine Protease Inhibitors Of Hepatitis C Virus

View page
US Patent:
7244721, Jul 17, 2007
Filed:
Jan 18, 2002
Appl. No.:
10/052386
Inventors:
Anil K. Saksena - Upper Montclair NJ, US
Viyyoor Moopil Girijavallabhan - Parsippany NJ, US
Raymond G. Lovey - West Caldwell NJ, US
Edwin Jao - Warren NJ, US
Frank Bennett - Piscataway NJ, US
Jinping L. Mc Cormick - Edison NJ, US
Haiyan Wang - Cranbury NJ, US
Russell E. Pike - Stanhope NJ, US
Stephane L. Bogen - Somerset NJ, US
Tin-Yau Chan - Edison NJ, US
Yi-Tsung Liu - Morris Township NJ, US
Zhaoning Zhu - East Windsor NJ, US
F. George Njoroge - Warren NJ, US
Ashok Arasappan - Bridgewater NJ, US
Tejal Parekh - Mountain View CA, US
Ashit K. Ganguly - Upper Montclair NJ, US
Kevin X. Chen - Iselin NJ, US
Srikanth Venkatraman - Woodbridge NJ, US
Henry A. Vaccaro - South Plainfield NJ, US
Patrick A. Pinto - Morris Plains NJ, US
Bama Santhanam - Bridgewater NJ, US
Scott Jeffrey Kemp - San Diego CA, US
Odile Esther Levy - San Diego CA, US
Marguerita Lim-Wilby - La Jolla CA, US
Susan Y. Tamura - San Diego CA, US
Wanli Wu - Edison NJ, US
Siska Hendrata - Rockaway NJ, US
Yuhua Huang - Scotch Plains NJ, US
Jesse K. Wong - Monroe Township NJ, US
Latha G. Nair - Scotch Plains NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
Dendreon Corporation - Seattle WA
International Classification:
A61K 31/497
A61K 31/407
A61K 31/454
A61K 31/4025
US Classification:
51421021, 530330, 530331
Abstract:
The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.

Peptides As Ns3-Serine Protease Inhibitors Of Hepatitis C Virus

View page
US Patent:
7595299, Sep 29, 2009
Filed:
Mar 24, 2005
Appl. No.:
11/089192
Inventors:
Anil Saksena - Upper Montclair NJ, US
Viyyoor M. Girijavallabhan - Parsippany NJ, US
Stephane L. Bogen - Somerset NJ, US
Raymond G. Lovey - West Caldwell NJ, US
Edwin Jao - Dayton MD, US
Frank Bennett - Cranford NJ, US
Jinping L. McCormick - Edison NJ, US
Haiyan Wang - Cranbury NJ, US
Russell E. Pike - Stanhope NJ, US
Yi-Tsung Liu - Morris Township NJ, US
Tin-Yau Chan - Edison NJ, US
Zhaoning Zhu - East Windsor NJ, US
Ashok Arasappan - Bridgewater NJ, US
Kevin X. Chen - Iselin NJ, US
Srikanth Venkatraman - Fords NJ, US
Tejal Parekh - Mountain View CA, US
Patrick A. Pinto - Morris Plains NJ, US
Bama Santhanam - Bridgewater NJ, US
F. George Njoroge - Warren NJ, US
Ashit K. Ganguly - Upper Montclair NJ, US
Henry A. Vaccaro - South Plainfield NJ, US
Scott Jeffrey Kemp - San Diego CA, US
Odile Esther Levy - San Diego CA, US
Marguerita Lim-Wilby - La Jolla CA, US
Susan Y. Tamura - Santa Fe NM, US
Assignee:
Schering Corporation - Kenilworth NJ
Dendreon Corporation - Seattle WA
International Classification:
A61K 38/00
US Classification:
514 17, 514 18, 514616
Abstract:
The present invention discloses novel peptide compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.

Peptides As Ns3-Serine Protease Inhibitors Of Hepatitis C Virus

View page
US Patent:
RE43298, Apr 3, 2012
Filed:
Apr 22, 2011
Appl. No.:
13/068159
Inventors:
Anil K. Saksena - Upper Montclair NJ, US
Viyyoor Moopil Girijavallabhan - Parsippany NJ, US
Raymond G. Lovey - West Caldwell NJ, US
Edwin Jao - Warren NJ, US
Frank Bennett - Cranford NJ, US
Jinping L. McCormick - Edison NJ, US
Haiyan Wang - Cranbury NJ, US
Russell E. Pike - Stanhope NJ, US
Stephane L. Bogen - Somerset NJ, US
Tin-Yau Chan - Edison NJ, US
Yi-Tsung Liu - Morris Township NJ, US
Zhaoning Zhu - East Windsor NJ, US
F. George Njoroge - Warren NJ, US
Ashok Arasappan - Bridgewater NJ, US
Tejal Parekh - Mountain View CA, US
Ashit K. Ganguly - Upper Montclair NJ, US
Kevin X. Chen - Edison NJ, US
Srikanth Venkatraman - Fords NJ, US
Henry M. Vaccaro - South Plainfield NJ, US
Patrick A. Pinto - Morris Plains NJ, US
Bama Santhanam - Bridgewater NJ, US
Scott Jeffrey Kemp - San Diego CA, US
Odile Esther Levy - San Diego CA, US
Marguerita Lim-Wilby - Santa Fe NM, US
Susan Y. Tamura - Santa Fe NM, US
Wanli Wu - Edison NJ, US
Siska Hendrata - Edison NJ, US
Yuhua Huang - Scotch Plains NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
Dendreon Corporation - San Diego CA
International Classification:
A61K 38/00
A01N 37/18
A61P 1/16
A61P 31/12
A61K 39/12
G01N 33/53
A61K 38/07
A61K 38/06
C07K 5/08
C07K 5/10
US Classification:
514 43, 514 37, 4241491, 436820, 530300, 530330, 530331
Abstract:
The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.

Novel Peptides As Ns3-Serine Protease Inhibitors Of Hepatitis C Virus

View page
US Patent:
20030036501, Feb 20, 2003
Filed:
Jul 19, 2001
Appl. No.:
09/909062
Inventors:
Anil Saksena - Upper Montclair NJ, US
Viyyoor Girijavallabhan - Parsippany NJ, US
Raymond Lovey - West Caldwell NJ, US
Edwin Jao - Warren NJ, US
Frank Bennett - Piscataway NJ, US
Jinping McCormick - Edison NJ, US
Haiyan Wang - Cranbury NJ, US
Russell Pike - Stanhope NJ, US
Stephane Bogen - Somerset NJ, US
Yi-Tsung Liu - Morris Township NJ, US
Ashok Arasappan - Bridgewater NJ, US
Tejal Parekh - Mountain View CA, US
Patrick Pinto - Morris Plains NJ, US
F. Njoroge - Warren NJ, US
Ashit Ganguly - Upper Mountclair NJ, US
Terence Brunck - Santa Fe NM, US
Scott Kemp - San Diego CA, US
Odile Levy - San Diego CA, US
Marguerita Lim-Wilby - La Jolla CA, US
International Classification:
A01N037/18
A61K038/00
US Classification:
514/002000
Abstract:
The present invention discloses novel peptide compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such peptides as well as methods of using them to treat disorders associated with the HCV protease.

Novel Peptides As Ns3-Serine Protease Inhibitors Of Hepatitis C Virus

View page
US Patent:
20050059606, Mar 17, 2005
Filed:
Sep 3, 2004
Appl. No.:
10/934141
Inventors:
Anil Saksena - Upper Montclair NJ, US
Viyyoor Girijavallabhan - Parsippany NJ, US
Raymond Lovey - West Caldwell NJ, US
Edwin Jao - Warren NJ, US
Ashok Arasappan - Bridgewater NJ, US
Tejal Parekh - Mountain View CA, US
Patrick Pinto - Morris Plains NJ, US
Frank Bennett - Cranford NJ, US
Jinping McCormick - Edison NJ, US
Haiyan Wang - Cranbury NJ, US
Russell Pike - Stanhope NJ, US
Stephane Bogen - Somerset NJ, US
Yi-Tsung Liu - Morris Township NJ, US
F. Njoroge - Warren NJ, US
Ashit Ganguly - Upper Montclair NJ, US
Terence Brunck - Santa Fe NM, US
Scott Kemp - San Diego CA, US
Odile Levy - San Diego CA, US
Marguerita Lim-Wilby - La Jolla CA, US
Assignee:
Dendreon Corporation - San Diego CA
Schering Corporation - Kenilworth NJ
International Classification:
A61K038/08
C07K007/06
US Classification:
514017000, 530329000
Abstract:
The present invention discloses novel peptide compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such peptides as well as methods of using them to treat disorders associated with the HCV protease.
Control profile
Tejal C Parekh from Union City, NJ, age ~34 Get Report